Gene · 871
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacokinetics, safety, and tolerability of BMS-986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment. | Clin Transl Sci | 2023 | 37654022 | PubTator, text mining | PubMed |
| Breast stiffness, a risk factor for cancer and the role of radiology for diagnosis. | J Transl Med | 2023 | 37649088 | PubTator, text mining | PubMed |
| Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes. | Circ Res | 2023 | 37646165 | PubTator, text mining | PubMed |
| Correction to: Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma. | Cancer Cell Int | 2023 | 37644494 | PubTator, text mining | PubMed |
| Structure of Vibrio Phage XM1, a Simple Contractile DNA Injection Machine. | Viruses | 2023 | 37632015 | PubTator, text mining | PubMed |
| Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies. | Int J Mol Sci | 2023 | 37628834 | PubTator, text mining | PubMed |
| Emergent Peptides of the Antifibrotic Arsenal: Taking Aim at Myofibroblast Promoting Pathways. | Biomolecules | 2023 | 37627244 | PubTator, text mining | PubMed |
| Identification of hub genes and key signaling pathways by weighted gene co-expression network analysis for human aortic stenosis and insufficiency. | Front Cardiovasc Med | 2023 | 37621558 | PubTator, text mining | PubMed |
| Identification of a gene set that maintains tumorigenicity of the hepatocellular carcinoma cell line Li-7. | Hum Cell | 2023 | 37610679 | PubTator, text mining | PubMed |
| Clinical and molecular description of the first Italian cohort of 33 subjects with hypophosphatasia. | Front Endocrinol (Lausanne) | 2023 | 37600704 | PubTator, text mining | PubMed |
| The applications of functional materials-based nano-formulations in the prevention, diagnosis and treatment of chronic inflammation-related diseases. | Front Pharmacol | 2023 | 37593176 | PubTator, text mining | PubMed |
| Identification of survival-associated biomarkers based on three datasets by bioinformatics analysis in gastric cancer. | World J Clin Cases | 2023 | 37584004 | PubTator, text mining | PubMed |
| Zoledronic Acid Treatment in Infants and Toddlers with Osteogenesis Imperfecta is Safe and Effective: A Tertiary Care Centre Experience. | Indian J Endocrinol Metab | 2023 | 37583407 | PubTator, text mining | PubMed |
| New progress of tuberculosis scar carcinoma. | Cancer Metastasis Rev | 2023 | 37582896 | PubTator, text mining | PubMed |
| Retraction: Photoactivatable Hsp47: A Tool to Regulate Collagen Secretion and Assembly. | Adv Sci (Weinh) | 2023 | 37582689 | PubTator, text mining | PubMed |
| Natural compound fraxinellone ameliorates intestinal fibrosis in mice via direct intervention of HSP47-collagen interaction in the epithelium. | Acta Pharmacol Sin | 2023 | 37580493 | PubTator, text mining | PubMed |
| Inflammatory Bowel Diseases: An Updated Overview on the Heat Shock Protein Involvement. | Int J Mol Sci | 2023 | 37569505 | PubTator, text mining | PubMed |
| The Golgi Apparatus: A Voyage through Time, Structure, Function and Implication in Neurodegenerative Disorders. | Cells | 2023 | 37566051 | PubTator, text mining | PubMed |
| Pathogenic mechanisms of osteogenesis imperfecta, evidence for classification. | Orphanet J Rare Dis | 2023 | 37559063 | PubTator, text mining | PubMed |
| New insights into RNA processing by the eukaryotic tRNA splicing endonuclease. | J Biol Chem | 2023 | 37544645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/papers?page=15